Idogen
Idogen presentation - Idogen
Idogen AB Interim report January–September 2019 - Idogen
Sharon Longhurst - Idogen
Idogen publishes prospectus in connection with the forthcoming rights issue - Nordic Life Science – the leading Nordic life science news service
IPOs, Shares and European Stock Exchange News | IPO HUB
PDF) Comparative secretome of ovarian serous carcinoma: Gelsolin in the spotlight
Idogen appoints Anders Karlsson as new CEO - Idogen
Mikael Oerum – Board Member – Cube Labs | LinkedIn
Idogen - Crunchbase Company Profile & Funding
Idogen
Approved study and prestigious meetings in fibrosis put Cereno Scientific in the limelight - BioStock
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Idogen's first trading day on Nasdaq First North noted at Times Square in New York - Idogen
Idogen - Crunchbase Company Profile & Funding
ABOUT US | abbreos
Idogen Annual report 2018 - Idogen
Idogen
Idogen - Crunchbase Company Profile & Funding
Idogen - Crunchbase Company Profile & Funding
Logga till PM - Idogen
Portfolio Companies - Ventac Partners
